Want to see KR:090370 full AI Analyst Report?
090370 Stock Chart & Stats
₩967.00
-₩7.00(-0.72%)
―
--
Day’s Range― - ―
52-Week Range₩911.00 - ₩2,630.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)18.51K
Market Cap
₩26.40B
Enterprise Value₩187.06B
Total Cash (Recent Filing)₩12.43B
Total Debt (Recent Filing)₩102.12B
Price to Earnings (P/E)―
Beta0.22
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.53%
Share Statistics
EPS (TTM)N/A
Shares Outstanding27,304,690
10 Day Avg. Volume19,889
30 Day Avg. Volume18,514
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.59
Price to Sales (P/S)0.50
P/FCF Ratio-10.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthRevenue growth provides evidence that demand or commercial activity is expanding despite the company’s weak current profitability. If this momentum persists, it can improve operating leverage, support greater scale, and create a foundation for restoring positive earnings over the next several quarters.
Positive Cash GenerationA return to positive operating and free cash flow improves near-term financial resilience and gives the company internally generated funds for operations. Positive cash generation despite a net loss suggests recent working-capital discipline or lower investment intensity is supporting liquidity.
Improving Operating TrendThe improvement from 2025 indicates that operating performance is moving in a better direction, even though the company remains loss-making on a TTM basis. A sustained recovery in EBITDA could eventually support break-even earnings and improve the quality of cash generation.
Bears Say
Persistent Losses And Low MarginsLow gross profitability and continued operating losses show that revenue growth is not yet translating into durable earnings power. This limits self-funded expansion, leaves less room to absorb cost pressure, and makes the company’s recovery dependent on sustained operational improvement.
Rising LeverageThe sharp increase in leverage raises the company’s financial risk while returns remain negative. Greater borrowing can constrain future capital allocation and increase exposure to financing costs or refinancing needs, reducing flexibility if the earnings recovery takes longer than expected.
Volatile Cash FlowsRecent positive cash flow is encouraging, but the historical swings weaken confidence that current cash generation is durable. Persistent volatility can complicate budgeting, debt management, and investment planning, particularly while the business remains loss-making and more leveraged.
090370 FAQ
What was MetaLabs Co., Ltd.’s price range in the past 12 months?
MetaLabs Co., Ltd. lowest stock price was ₩911.00 and its highest was ₩2630.00 in the past 12 months.
What is MetaLabs Co., Ltd.’s market cap?
MetaLabs Co., Ltd.’s market cap is ₩26.40B.
When is MetaLabs Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MetaLabs Co., Ltd.’s earnings last quarter?
Currently, no data Available
Is MetaLabs Co., Ltd. overvalued?
According to Wall Street analysts MetaLabs Co., Ltd.’s price is currently Undervalued.
Does MetaLabs Co., Ltd. pay dividends?
MetaLabs Co., Ltd. pays a Annually dividend of ₩682.724 which represents an annual dividend yield of 0.53%. See more information on MetaLabs Co., Ltd. dividends here
What is MetaLabs Co., Ltd.’s EPS estimate?
MetaLabs Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MetaLabs Co., Ltd. have?
MetaLabs Co., Ltd. has 27,304,690 shares outstanding.
What happened to MetaLabs Co., Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of MetaLabs Co., Ltd.?
Currently, no hedge funds are holding shares in KR:090370
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MetaLabs Co., Ltd.
Metalabs Co., Ltd. primarily engages in the supply of clothing across South Korea. Its operations are multifaceted, also encompassing the manufacturing and distribution of pharmaceutical drugs, medical devices, and masks. The company further dedicates efforts to developing peptide-based biotechnological products, providing medical management solutions, distributing cosmetics, and overseeing dating applications. Founded in 2000 and based in Seoul, South Korea, the entity was formerly known as Avista Inc. until it adopted the name Metalabs Co., Ltd. in April 2018.